Arterial Stiffness and Chronic Kidney Disease Progression in Children.


Journal

Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570

Informations de publication

Date de publication:
10 2022
Historique:
received: 19 02 2022
accepted: 27 07 2022
pubmed: 26 8 2022
medline: 14 1 2023
entrez: 25 8 2022
Statut: ppublish

Résumé

CKD has been linked to increased arterial stiffness in adults, but data in children with CKD remain conflicting. We aimed to investigate the longitudinal dynamics and determinants of pulse wave velocity in children with CKD and its association with CKD progression. We performed an analysis of the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study, which prospectively followed children aged 6-17 years with CKD stages 3-5. Follow-up was censored at the time of KRT initiation. Two separate analyses were performed: with absolute pulse wave velocity (primary outcome) and with pulse wave velocity standardized to height ( In total, 667 patients with a mean baseline eGFR of 27 ml/min per 1.73 m Pulse wave velocity is increased in children with CKD but does not associate with eGFR or CKD progression.

Sections du résumé

BACKGROUND AND OBJECTIVES
CKD has been linked to increased arterial stiffness in adults, but data in children with CKD remain conflicting. We aimed to investigate the longitudinal dynamics and determinants of pulse wave velocity in children with CKD and its association with CKD progression.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS
We performed an analysis of the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study, which prospectively followed children aged 6-17 years with CKD stages 3-5. Follow-up was censored at the time of KRT initiation. Two separate analyses were performed: with absolute pulse wave velocity (primary outcome) and with pulse wave velocity standardized to height (
RESULTS
In total, 667 patients with a mean baseline eGFR of 27 ml/min per 1.73 m
CONCLUSIONS
Pulse wave velocity is increased in children with CKD but does not associate with eGFR or CKD progression.

Identifiants

pubmed: 36008353
pii: 01277230-202210000-00008
doi: 10.2215/CJN.02200222
pmc: PMC9528270
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1467-1476

Informations de copyright

Copyright © 2022 by the American Society of Nephrology.

Références

de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS, Mietus-Snyder M, Mitsnefes MM, Peterson AL, St-Pierre J, Urbina EM, Zachariah JP, Zaidi AN: Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association. Circulation 139: e603–e634, 2019
Shroff R, Long DA, Shanahan C: Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24: 179–189, 2013
Briet M, Burns KD: Chronic kidney disease and vascular remodelling: Molecular mechanisms and clinical implications. Clin Sci (Lond) 123: 399–416, 2012
Sedaghat S, Mattace-Raso FUS, Hoorn EJ, Uitterlinden AG, Hofman A, Ikram MA, Franco OH, Dehghan A: Arterial stiffness and decline in kidney function. Clin J Am Soc Nephrol 10: 2190–2197, 2015
Townsend RR, Anderson AH, Chirinos JA, Feldman HI, Grunwald JE, Nessel L, Roy J, Weir MR, Wright Jr. JT, Bansal N, Hsu CY; CRIC Study Investigators: Association of pulse wave velocity with chronic kidney disease progression and mortality: Findings from the CRIC study (Chronic Renal Insufficiency Cohort). Hypertension 71: 1101–1107, 2018
Azukaitis K, Jankauskiene A, Schaefer F, Shroff R: Pathophysiology and consequences of arterial stiffness in children with chronic kidney disease. Pediatr Nephrol 36: 1683–1695, 2021
Sinha MD, Keehn L, Milne L, Sofocleous P, Chowienczyk PJ: Decreased arterial elasticity in children with nondialysis chronic kidney disease is related to blood pressure and not to glomerular filtration rate. Hypertension 66: 809–815, 2015
Savant JD, Betoko A, Meyers KEC, Mitsnefes M, Flynn JT, Townsend RR, Greenbaum LA, Dart A, Warady B, Furth SL: Vascular stiffness in children with chronic kidney disease. Hypertension 69: 863–869, 2017
Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, Civilibal M, Doyon A, Duzova A, Kracht D, Litwin M, Melk A, Mir S, Sözeri B, Shroff R, Zeller R, Wühl E, Schaefer F; 4C Study Group: The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: Objectives, design, and methodology. Clin J Am Soc Nephrol 5: 1642–1648, 2010
Kracht D, Shroff R, Baig S, Doyon A, Jacobi C, Zeller R, Querfeld U, Schaefer F, Wühl E, Schmidt BMW, Melk A; 4C Study Consortium: Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents. Am J Hypertens 24: 1294–1299, 2011
Thurn D, Doyon A, Sözeri B, Bayazit AK, Canpolat N, Duzova A, Querfeld U, Schmidt BMW, Schaefer F, Wühl E, Melk A; 4C Study Consortium: Aortic pulse wave velocity in healthy children and adolescents: Reference values for the Vicorder device and modifying factors. Am J Hypertens 28: 1480–1488, 2015
Kis E, Cseprekál O, Horváth Z, Katona G, Fekete BC, Hrapka E, Szabó A, Szabó AJ, Fekete A, Reusz GS: Pulse wave velocity in end-stage renal disease: Influence of age and body dimensions. Pediatr Res 63: 95–98, 2008
Cseprekál O, Kis E, Schäffer P, Othmane TH, Fekete BC, Vannay A, Szabó AJ, Remport A, Szabó A, Tulassay T, Reusz GS: Pulse wave velocity in children following renal transplantation. Nephrol Dial Transplant 24: 309–315, 2009
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J: Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85: 660–667, 2007
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114[Suppl 4th Report]: 555–576, 2004
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wühl E, Zanchetti A: 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34: 1887–1920, 2016
Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629–637, 2009
Cole TJ, Green PJ: Smoothing reference centile curves: The LMS method and penalized likelihood. Stat Med 11: 1305–1319, 1992
Vlachopoulos C, Aznaouridis K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol 55: 1318–1327, 2010
Kouis P, Kousios A, Kanari A, Kleopa D, Papatheodorou SI, Panayiotou AG: Association of non-invasive measures of subclinical atherosclerosis and arterial stiffness with mortality and major cardiovascular events in chronic kidney disease: Systematic review and meta-analysis of cohort studies. Clin Kidney J 13: 842–854, 2019
Townsend RR: Arterial stiffness and chronic kidney disease: Lessons from the Chronic Renal Insufficiency Cohort study. Curr Opin Nephrol Hypertens 24: 47–53, 2015
Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, Niemirska A, Sözeri B, Thurn D, Anarat A, Ranchin B, Litwin M, Caliskan S, Candan C, Baskin E, Yilmaz E, Mir S, Kirchner M, Sander A, Haffner D, Melk A, Wühl E, Shroff R, Querfeld U; 4C Study Consortium: Cardiovascular phenotypes in children with CKD: The 4C study. Clin J Am Soc Nephrol 12: 19–28, 2017
Skrzypczyk P, Okarska-Napierała M, Stelmaszczyk-Emmel A, Górska E, Pańczyk-Tomaszewska M: Renalase in children with chronic kidney disease. Biomarkers 24: 638–644, 2019
Hsu C-N, Lu P-C, Lo M-H, Lin I-C, Chang-Chien G-P, Lin S, Tain Y-L: Gut microbiota-dependent trimethylamine N -oxide pathway associated with cardiovascular risk in children with early-stage chronic kidney disease. Int J Mol Sci 19: 3699, 2018
Hsu C-N, Lu P-C, Lo M-H, Lin I-C, Tain Y-L: The association between nitric oxide pathway, blood pressure abnormalities, and cardiovascular risk profile in pediatric chronic kidney disease. Int J Mol Sci 20: 5301, 2019
Düzova A, Karabay Bayazit A, Canpolat N, Niemirska A, Kaplan Bulut I, Azukaitis K, Karagoz T, Oguz B, Erdem S, Anarat A, Ranchin B, Shroff R, Djukic M, Harambat J, Yilmaz A, Yildiz N, Ozcakar B, Büscher A, Lugani F, Wygoda S, Tschumi S, Zaloszyc A, Jankauskiene A, Laube G, Galiano M, Kirchner M, Querfeld U, Melk A, Schaefer F, Wühl E; 4C Study Consortium: Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: Findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study. J Hypertens 37: 2247–2255, 2019
Obrycki Ł, Feber J, Derezinski T, Lewandowska W, Kułaga Z, Litwin M: Hemodynamic patterns and target organ damage in adolescents with ambulatory prehypertension. Hypertension 75: 826–834, 2020
Sugianto RI, Memaran N, Schmidt BMW, Doyon A, Thurn-Valsassina D, Alpay H, Anarat A, Arbeiter K, Azukaitis K, Bayazit AK, Bulut IK, Caliskan S, Canpolat N, Duzova A, Gellerman J, Harambat J, Homeyer D, Litwin M, Mencarelli F, Obrycki L, Paripovic D, Ranchin B, Shroff R, Tegtbur U, von der Born J, Yilmaz E, Querfeld U, Wühl E, Schaefer F, Melk A: Findings from the 4C-T Study demonstrate an increased cardiovascular burden in girls with end stage kidney disease and kidney transplantation. Kidney Int 101: 585–596, 2022
Chirinos JA: Arterial stiffness: Basic concepts and measurement techniques. J Cardiovasc Transl Res 5: 243–255, 2012
Li Y, Gu H, Sinha MD, Chowienczyk P: Hemodynamic characterization of primary hypertension in children and adolescents. J Am Heart Assoc 9: e015097, 2020
Gaddum NR, Keehn L, Guilcher A, Gomez A, Brett S, Beerbaum P, Schaeffter T, Chowienczyk P: Altered dependence of aortic pulse wave velocity on transmural pressure in hypertension revealing structural change in the aortic wall. Hypertension 65: 362–369, 2015
Weir MR, Townsend RR, Fink JC, Teal V, Anderson C, Appel L, Chen J, He J, Litbarg N, Ojo A, Rahman M, Rosen L, Sozio SM, Steigerwalt S, Strauss L, Joffe MM: Hemodynamic correlates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol 6: 2403–2410, 2011
Pan CR, Roos M, Schmaderer C, Lutz J, Wang JG, Heemann U, Baumann M: Interrelationship between aortic stiffness and proteinuria in chronic kidney disease. J Hum Hypertens 24: 593–599, 2010
Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, Nelson RD, Kiessling SG, Brophy PD, Quiroga A, Seifert ME, Straatmann CE, Mahan JD, Ferris ME, Troost JP, Gipson DS: Vitamin D in incident nephrotic syndrome: A Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 31: 465–472, 2016
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503–511, 2008
Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA: Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58: 186–192, 2011
Ha JY, Kim MK, Kang S, Nam JS, Ahn CW, Kim KR, Park JS: Serum ferritin levels are associated with arterial stiffness in healthy Korean adults. Vasc Med 21: 325–330, 2016
Sciacqua A, Ventura E, Tripepi G, Cassano V, D’Arrigo G, Roumeliotis S, Maio R, Miceli S, Perticone M, Andreozzi F, Sesti G, Perticone F: Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance. Cardiovasc Diabetol 19: 123, 2020
Valenti L, Maloberti A, Signorini S, Milano M, Cesana F, Cappellini F, Dongiovanni P, Porzio M, Soriano F, Brambilla M, Cesana G, Brambilla P, Giannattasio C, Fargion S: Iron stores, hepcidin, and aortic stiffness in individuals with hypertension. PLoS One 10: e0134635, 2015
Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, Balla G: Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 49: 1030–1043, 2005
Zarjou A, Jeney V, Arosio P, Poli M, Antal-Szalmás P, Agarwal A, Balla G, Balla J: Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol 20: 1254–1263, 2009
Riggio S, Mandraffino G, Sardo MA, Iudicello R, Camarda N, Imbalzano E, Alibrandi A, Saitta C, Carerj S, Arrigo T, Saitta A: Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest 40: 250–257, 2010
Chen S-C, Huang J-C, Su H-M, Chiu Y-W, Chang J-M, Hwang S-J, Chen H-C: Prognostic cardiovascular markers in chronic kidney disease. Kidney Blood Press Res 43: 1388–1407, 2018
Elias MF, Davey A, Dore GA, Gillespie A, Abhayaratna WP, Robbins MA: Deterioration in renal function is associated with increased arterial stiffness. Am J Hypertens 27: 207–214, 2014
Chue CD, Edwards NC, Davis LJ, Steeds RP, Townend JN, Ferro CJ: Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant 26: 2576–2582, 2011
Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, Stengel B, Houillier P, Froissart M, Boutouyrie P; Nephrotest Study Group: Arterial remodeling associates with CKD progression. J Am Soc Nephrol 22: 967–974, 2011
Kim CS, Kim HY, Kang YU, Choi JS, Bae EH, Ma SK, Kim SW: Association of pulse wave velocity and pulse pressure with decline in kidney function. J Clin Hypertens (Greenwich) 16: 372–377, 2014
Ahearn P, Johansen KL, McCulloch CE, Grimes BA, Ku E: Sex disparities in risk of mortality among children with ESRD. Am J Kidney Dis 73: 156–162, 2019
Heinze G, Christensen J, Haller MC: Modeling pulse wave velocity trajectories-challenges, opportunities, and pitfalls. Kidney Int 101: 459–462, 2022

Auteurs

Karolis Azukaitis (K)

Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Marietta Kirchner (M)

Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.

Anke Doyon (A)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany.

Mieczysław Litwin (M)

Department of Nephrology and Arterial Hypertension, Children's Memorial Health Institute, Warsaw, Poland.

Aysun Bayazit (A)

Department of Pediatric Nephrology, Cukurova University, Adana, Turkey.

Ali Duzova (A)

Division of Pediatric Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Nur Canpolat (N)

Department of Pediatric Nephrology, Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.

Augustina Jankauskiene (A)

Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Rukshana Shroff (R)

Renal Unit, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.

Anette Melk (A)

Department of Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.

Uwe Querfeld (U)

Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Franz Schaefer (F)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH